Though convenient, SPF-infused cosmetics rarely deliver their labeled protection level in real-world use, underscoring the continued need for a dedicated broad-spectrum sunscreen as the foundation of any routine.
|Articles|January 1, 2004
Sweeping changes
Author(s)John Jesitus
Washington, D.C. - With a handful of new options expected to receive FDA approval within a year, the field of tissue augmentation stands poised to undergo a seismic shift. "The bottom line is, tissue augmentation is about to change dramatically," said Mariano E. Busso, M.D. He is clinical professor in the University of Miami's department of dermatology, chief of dermatology at Mercy Hospital, also in Miami, Fla., and a private practitioner who is board-certified in dermatology.
Advertisement
Advertisement
Related to this article
Genetic study links higher BMI to looking older, but causality stays unclear; Mendelian randomization flags shared signals and candidate genes needing validation.
Merz Aesthetics adds two FDA-approved Belotero HA fillers for midface volume and lip fullness, promising natural movement and long-lasting results.
Are beef tallow balms beneficial for the skin or are they just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.
FDA review of BOTOX Cosmetic for masseter prominence signals on-label jawline contouring, trial-backed results, clearer dosing guidance, and safer patient counseling.
LEO Pharma has closed its acquisition of dersimelagon from Tanabe Pharma after the FDA accepted the drug's NDA for filing and granted Priority Review, with a PDUFA date expected by the end of February 2027.
Sol-Gel Technologies has completed patient follow-up in its pivotal phase 3 trial of SGT-610 (patidegib gel, 2%) for Gorlin syndrome, with top-line results expected in late November 2026.
Two small clinical studies evaluated skincare and dermabrasion for changes in skin quality among individuals taking medical weight loss medications.
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Topical Solution Shows Long-Term Promise for Male Pattern Hair Loss
2
Neutrogena Launches New Sunscreens With Newly Permitted UV Filter Bemotrizinol
3
Maui Derm NP+PA Fall 2026 Day 2: GLP-1s, Inflammatory Disease, and Diagnostic Challenges
4
Dersimelagon NDA Accepted by FDA with Priority Review for EPP, XLP
5